<DOC>
	<DOCNO>NCT00652639</DOCNO>
	<brief_summary>To compare single-dose bioavailability Clonazepam tablets 1 mg Klonopin tablets 1 mg</brief_summary>
	<brief_title>Bioavailability Study Clonazepam Tablets Under Fasting Conditions</brief_title>
	<detailed_description>To compare single -dose bioavailability kali 's Clonazepam tablets 1 mg Klonopin tablets 1 mg Roche pharmaceutical follow single oral dose fast condition .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>All subject select study alt least 18 year age.Females must non childbearing potential ( postmenopausal alt least 6 month surgically sterile ) Each subject shall give general physical examination within 28 day study . Such examination include , limited , blood pressure , general observation , history . Each female subject give serum pregnancy test part prestudy process . At end study , subject exit evaluation consist interim history , global evaluation , clinical laboratory measurement . Adequate blood urine sample obtain within 28 day begin first period end trail clinical laboratory . Clinical laboratory measurement include follow : Hematology : hemoglobin , hematocrit , red blood cell count ( differential ) Clinical Chemistry : creatinine , BUN , glucose , SGOT/ AST , SGPT/ALT , bilirubin , alkaline phosphate . Urine Analysis : pH , specific gravity , protein , glucose , ketone , bilirubin , occult blood cell . HIV Screen : ( Prestudy ) HepatitisB , C Screen : ( Prestudy ) Drugs Abuse Screen : ( Prestudy check dose period ) Electrocardiograms participate subject record initiation study file subject 's case report form . Subjects history chronic alcohol consumption ( past 2 year ) , drug addiction , serious gastrointestinal , renal , hepatic cardiovascular disease , tuberculosis epilepsy , asthma , ( pat 5 year ) , diabetes , psychosis glaucoma eligible study . Subjects whose clinical laboratory test value outside normal range may retested discretion clinical investigator . If clinical value outside range retesting , subject eligible participate study unless clinical investigator deem result significant . Subjects history allergic response class drug test excluded form study . All subject urine sample assay presence drug abuse part clinical laboratory screening procedure check dose period . Subjects find urine concentration test drug allow participate . Subjects donate blood and/plasma least thirty ( 30 ) day prior first dose study Subjects take investigational drug within thirty ( 30 ) day prior first dose study allow participate . Female subject childbearing potential allow participate . All female subject screen pregnancy check study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>bioequivalence , Clonazepam tablet , fast</keyword>
</DOC>